Overview of SARS-COV-2 infection at the butantan penitentiary progression center

Full metadata record
DC FieldValueLanguage
dc.contributorCentro de Ensaios Clínicos e Farmacovigilânciapt_BR
dc.contributor.authorAndrade, Soraya Gomes de Amorimpt_BR
dc.contributor.authorAndrade, Fernando Moreirapt_BR
dc.contributor.authorSilva, Anderson dapt_BR
dc.contributor.authorFerraz, Guilherme Rodriguespt_BR
dc.contributor.authorBarros, Eliana Nogueira Castro dept_BR
dc.contributor.authorBraga, Patrícia Emíliapt_BR
dc.date.accessioned2023-06-06T12:07:26Z-
dc.date.available2023-06-06T12:07:26Z-
dc.date.issued2023pt_BR
dc.identifier.citationAndrade SGA, Andrade FM, Silva A, Ferraz GR, Barros ENC, Braga PE. Overview of SARS-COV-2 infection at the butantan penitentiary progression center. Rev Saúde Publ. 2023 May; 57(1):10s. doi:10.11606/s1518-8787.2023057004717.pt_BR
dc.identifier.urihttps://repositorio.butantan.gov.br/handle/butantan/4941-
dc.description.abstractOBJECTIVE: To estimate the prevalence of exposure to the SARS-CoV-2 virus among individuals living in restricted freedom. METHODS: A seroprevalence survey was carried out with the population of the female penitentiary of the Centro de Progressão Penitenciária (CPP) in Butantan (municipality of São Paulo), between June 24 and August 20, 2020. During this period, according to the Secretariat of Penitentiary Administration (SAP), the positivity of rapid tests among inmates ranged from 65% to 78%. The evaluation method used in the study was the “One Step COVID-19” rapid test (chromatography), from the company Wondfo, also using the RT-PCR method in symptomatic participants to confirm the viral condition. The study population consisted of 879 female inmates and 170 employees of the institution. RESULTS: The prevalence of total antibodies (IgG/IgM) against the SARS-CoV-2 virus in the total population of 1049 study participants was 6.1%; among the population of 879 inmates, a prevalence of 5.8% was observed, and among the institution’s employees, 7.5%. CONCLUSIONS: The prevalence of covid-19 at the Butantan CPP was low, which is due to the implementation of simple prevention measures at the institution, such as the use of masks (with appropriate changes), emphasis on hygiene, hand washing and social distancing, in addition to other strategies, such as suspending inmates’ visits from relatives and friends and cutting back on elective medical appointments and outside work.pt_BR
dc.description.sponsorship(CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorpt_BR
dc.format.extent10spt_BR
dc.language.isoEnglishpt_BR
dc.relation.ispartofRevista de Saúde Públicapt_BR
dc.rightsOpen accesspt_BR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_BR
dc.titleOverview of SARS-COV-2 infection at the butantan penitentiary progression centerpt_BR
dc.typeArticlept_BR
dc.rights.licenseCC BYpt_BR
dc.identifier.doi10.11606/s1518-8787.2023057004717pt_BR
dc.contributor.external(USP) Universidade de São Paulopt_BR
dc.contributor.external(FCMSCSP) Faculdade de Ciências Médicas da Santa Casa de São Paulopt_BR
dc.contributor.externalCentro Universitário São Camilopt_BR
dc.identifier.citationvolume57pt_BR
dc.identifier.citationissue1pt_BR
dc.subject.keywordprisonerspt_BR
dc.subject.keywordSARS-CoV-2pt_BR
dc.subject.keywordCOVID-19 testingpt_BR
dc.subject.keywordrisk factorspt_BR
dc.subject.keywordprevalencept_BR
dc.subject.keywordprisonspt_BR
dc.relation.ispartofabbreviatedRev Saúde Publpt_BR
dc.identifier.citationabntv. 57, n. 1, 10s, mai. 2023pt_BR
dc.identifier.citationvancouver2023 May; 57(1):10spt_BR
dc.contributor.butantanSilva, Anderson da|:Outros|:Centro de Ensaios Clínicos e Farmacovigilância|:pt_BR
dc.contributor.butantanBarros, Eliana Nogueira Castro de|:Outros|:Centro de Ensaios Clínicos e Farmacovigilância|:pt_BR
dc.contributor.butantanBraga, Patrícia Emília|:Pesquisador|:Centro de Ensaios Clínicos e Farmacovigilância|:pt_BR
dc.sponsorship.butantan(CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior¦¦001pt_BR
dc.identifier.bvsccBR78.1pt_BR
dc.identifier.bvsdbIBProdpt_BR
dc.description.dbindexedYespt_BR
item.openairetypeArticle-
item.grantfulltextopen-
item.languageiso639-1English-
item.fulltextCom Texto completo-
crisitem.journal.journalissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journaleissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid0000-0003-3442-2343-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
Appears in Collections:Artigos


Files in This Item:

Show simple item record

This item is licensed under a Creative Commons License Creative Commons